Exact Mass: 299.0004444
Exact Mass Matches: 299.0004444
Found 150 metabolites which its exact mass value is equals to given mass value 299.0004444,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2-Methyl-4-amino-5-hydroxymethylpyrimidine diphosphate
azane;dichloroplatinum
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XA - Platinum compounds D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003432 - Cross-Linking Reagents
AZACONAZOLE
C254 - Anti-Infective Agent > C514 - Antifungal Agent CONFIDENCE standard compound; INTERNAL_ID 566; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8662; ORIGINAL_PRECURSOR_SCAN_NO 8657 CONFIDENCE standard compound; INTERNAL_ID 566; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8706; ORIGINAL_PRECURSOR_SCAN_NO 8705 CONFIDENCE standard compound; INTERNAL_ID 566; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8723; ORIGINAL_PRECURSOR_SCAN_NO 8721 ORIGINAL_PRECURSOR_SCAN_NO 8757; ORIGINAL_ACQUISITION_NO 8758; CONFIDENCE standard compound; INTERNAL_ID 566; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0 CONFIDENCE standard compound; INTERNAL_ID 566; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8758; ORIGINAL_PRECURSOR_SCAN_NO 8757 CONFIDENCE standard compound; INTERNAL_ID 566; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8758; ORIGINAL_PRECURSOR_SCAN_NO 8756 CONFIDENCE standard compound; INTERNAL_ID 566; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8772; ORIGINAL_PRECURSOR_SCAN_NO 8771
[Nitrilotris(methylene)]trisphosphonic acid
C3H12NO9P3 (298.97249320000003)
Corrosion inhibitor, complexing agent, e.g. for scale control, and demetallisation of wines. [Nitrilotris(methylene)]trisphosphonic acid is a permitted for treatment of cooling and retort water for meat and poultry product
Creatinine citrate
4-Amino-5-hydroxymethyl-2-methylpyrimidine diphosphate
4-Amino-2-chloro-5(methylsulfamyl)benzenesulfonamide
2-acetamido-3-(2,3-dihydroxybenzoylthio)propanoic acid
Ticlopidine Hydrochloride
C14H15Cl2NS (299.03022100000004)
D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065689 - Cytochrome P-450 CYP2C19 Inhibitors C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent > C190801 - P2Y12 Inhibitor D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents Ticlopidine hydrochloride is an adenosine diphosphate (ADP) receptor inhibitor against platelet aggregation with IC50 of ~2 μM. Target: Adenosine diphosphate (ADP) Ticlopidine (trade name Ticlid) is an antiplatelet drug in the thienopyridine family. Ticlopidine hydrochloride inhibits platelet aggregation with IC50 of ~2 μM in men. Like clopidogrel, it is an adenosine diphosphate (ADP) receptor inhibitor. It is used in patients in whom aspirin is not tolerated, or in whom dual antiplatelet therapy is desirable. Because it has been reported to increase the risk of thrombotic thrombocytopenic purpura (TTP) and neutropenia, its use has largely been supplanted by the newer drug, clopidogrel, which is felt to have a much lower hematologic risk. Its niche role as an alternative in those patients who do not tolerate Clopidogrel has now been superdeded by Ticagrelor and Prasugrel. The usual dose is 250 mg twice daily by the oral route. Ticlopidine hydrochloride, when orally administered to rats, results in activation of basal and prostaglandin E1 (PGE1)-stimulated adenylate cylase activity through increase in affinity of the cyclase in platelet membrane to PGE1, although it failed to affect adenosine- or sodium fluoride-stimulated activity of the enzyme.
CP-607366
CONFIDENCE standard compound; INTERNAL_ID 1322; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8103; ORIGINAL_PRECURSOR_SCAN_NO 8101 CONFIDENCE standard compound; INTERNAL_ID 1322; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8111; ORIGINAL_PRECURSOR_SCAN_NO 8107 CONFIDENCE standard compound; INTERNAL_ID 1322; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8129; ORIGINAL_PRECURSOR_SCAN_NO 8127 CONFIDENCE standard compound; INTERNAL_ID 1322; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8133; ORIGINAL_PRECURSOR_SCAN_NO 8131 CONFIDENCE standard compound; INTERNAL_ID 1322; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8132; ORIGINAL_PRECURSOR_SCAN_NO 8131 CONFIDENCE standard compound; INTERNAL_ID 1322; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8150; ORIGINAL_PRECURSOR_SCAN_NO 8149
Dowell L 37
C3H12NO9P3 (298.97249320000003)
benzyl N-(1,1,1,3,3,3-hexafluoropropan-2-ylidene)carbamate
ETHYL 2-(CHLOROMETHYL)-4-METHYLQUINOLINE-3-CARBOXYLATE HYDROCHLORIDE
potassium,[3,4,5-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl dihydrogen phosphate
3-AMINO-3-[5-(2,4-DICHLOROPHENYL)-FURAN-2-YL]-PROPIONIC ACID
3-AMINO-3-[5-(2,5-DICHLOROPHENYL)-FURAN-2-YL]-PROPIONIC ACID
3-AMINO-3-[5-(3,4-DICHLOROPHENYL)-FURAN-2-YL]-PROPIONIC ACID
3-(4-NITRO-PHENYL)-2-THIOXO-2,3-DIHYDRO-1H-QUINAZOLIN-4-ONE
methyl 1-(5-bromopyrimidin-2-yl)piperidine-4-carboxylate
6-CHLORO-2-(4-HYDROXY-PHENYL)-QUINOLINE-4-CARBOXYLIC ACID
2-[[(4-AMINOPHENYL)SULFONYL]AMINO]-4-THIAZOLECARBOXYLIC ACID
C10H9N3O4S2 (299.00344739999997)
METHYL 8-BROMO-6-FLUORO-4-OXO-1,4-DIHYDROQUINOLINE-2-CARBOXYLATE
1-(8-methyl-6-oxo-[1,3]dioxolo[4,5-g]chromen-7-yl)pyrrole-2,5-dione
ETHANETHIONE, 2-(3-BROMOPHENYL)-1-(4-MORPHOLINYL)-
C12H14BrNOS (298.99794140000006)
2,6-Diamino-4-(4-nitrophenyl)-4H-thiopyran-3,5-dicarbonitrile
N-[3-(1-IMidazolyl)propyl]-4-chlorobenzenesulfonamide
2-chloro-1-methylpyridinium p-toluenesulfonate
C13H14ClNO3S (299.03828840000006)
6-Nitro-4-oxo-7-(trifluoromethoxy)-1,4-dihydro-3-quinolinecarboni trile
C11H4F3N3O4 (299.01538999999997)
gemcitabine hydrochloride
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2150 - Ribonucleotide Reductase Inhibitor D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Gemcitabine Hydrochloride (LY 188011 Hydrochloride) is a pyrimidine nucleoside analog antimetabolite and an antineoplastic agent. Gemcitabine Hydrochloride inhibits DNA synthesis and repair, resulting in autophagyand apoptosis[1][2].
2,6-diamino-4-(2-nitrophenyl)-4H-thiopyran-3,5-dicarbonitrile
ethyl 5-amino-1-(2,4-dichlorophenyl)pyrazole-4-carboxylate
6-CHLORO-2-(2-HYDROXY-PHENYL)-QUINOLINE-4-CARBOXYLIC ACID
4-(2,4-DICHLOROPHENYL)-1,4,5,6-TETRAHYDRO-2-METHYL-6-OXO-3-PYRIDINECARBOXYLIC ACID
1H-Pyrazole-3-carboxylic acid, 4-[(2,6-dichlorobenzoyl)amino]-
8-CHLORO-1-CYCLOPROPYL-6,7-DIFLUORO-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID
N-PHENYL-1-NAPHTHYLAMINE HYDROBROMIDE,
C16H14BrN (299.03095440000004)
Ferric citrate trihydrate
D006401 - Hematologic Agents > D006397 - Hematinics > D005290 - Ferric Compounds
5-bromo-2-hydroxy-3-(morpholin-4-ylmethyl)benzaldehyde
ETHANETHIONE, 2-(4-BROMOPHENYL)-1-(4-MORPHOLINYL)-
C12H14BrNOS (298.99794140000006)
2,4-diphenyl-1,3-thiazole-5-carbonyl chloride
C16H10ClNOS (299.01716000000005)
2-[(2,3-dioxo-1,4-dihydroquinoxalin-6-yl)sulfonylamino]acetic acid
N-(3-BROMOPROPYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE
6-bromo-4,4-diethyl-1h-benzo[d][1,3]oxazine-2(4h)-thione
C12H14BrNOS (298.99794140000006)
Pantothenic acid-13C3,15N hemicalcium
C9H17NO5.1/2Ca (299.03584920000003)
2,6-diamino-4-(3-nitrophenyl)-4H-thiopyran-3,5-dicarbonitrile
Pyridine, 3-bromo-2-(4-methyl-1-piperidinyl)-5-nitro-
METHYL 8-BROMO-5-FLUORO-4-HYDROXYQUINOLINE-2-CARBOXYLATE
Durlobactam sodium
C8H10N3NaO6S (299.01880000000006)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D065093 - beta-Lactamase Inhibitors C254 - Anti-Infective Agent > C258 - Antibiotic D004791 - Enzyme Inhibitors
Traxanox
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D018501 - Antirheumatic Agents > D006074 - Gout Suppressants > D014528 - Uricosuric Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics
4-Amino-5-oxo-1-(p-sulphophenyl)-2-pyrazoline-3-carboxylic acid
2-(Dichloromethyl)-4-(ethylthio)-6-phenyl-1,3,5-triazine
C12H11Cl2N3S (299.00507060000007)
3-(p-Tolylsulfonylamino)-5-fluorouracil
C11H10FN3O4S (299.03760320000004)
trans-Platin
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003432 - Cross-Linking Reagents D011838 - Radiation-Sensitizing Agents D000970 - Antineoplastic Agents
N-acetyl-D-glucosamine 6-phosphate(2-)
C8H14NO9P-2 (299.04061640000003)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
N-acetyl-alpha-D-glucosamine 1-phosphate(2-)
C8H14NO9P-2 (299.04061640000003)
N-acetyl-alpha-D-galactosamine 1-phosphate(2-)
C8H14NO9P-2 (299.04061640000003)
N-acetyl-D-galactosamine 6-phosphate(2-)
C8H14NO9P-2 (299.04061640000003)
2-bromo-N-[(2R,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
N-acetyl-beta-D-glucosamine 6-phosphate(2-)
C8H14NO9P-2 (299.04061640000003)
an N-acetyl-alpha-D-hexosamine 1-phosphate
C8H14NO9P-2 (299.04061640000003)
N-acetyl-D-mannosamine 1-phosphate
C8H14NO9P-2 (299.04061640000003)
N-acetyl-alpha-D-glucosamine 6-phosphate
C8H14NO9P-2 (299.04061640000003)
9-Hydroxy-15-methyl-6,12,13-trioxa-3,5,15-triazatricyclo[7.3.2.11,4]pentadec-4-ene-2,7,11,14-tetrone
2-Deoxy-2,2-difluorocytidine monohydrochloride
D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents
Ticlid
C14H15Cl2NS (299.03022100000004)
D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065689 - Cytochrome P-450 CYP2C19 Inhibitors D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents
N-acetyl-D-mannosamine 6-phosphate(2-)
C8H14NO9P-2 (299.04061640000003)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
3,4-dichloro-N-(2-thiophen-2-ylethyl)benzamide
C13H11Cl2NOS (298.99383760000006)
2-(2,4-dichlorophenoxy)-N-(2-furanylmethyl)acetamide
Tazobactam(1-)
A penicillinate anion that is the conjugate base of tazobactam, obtained by deprotonation of the carboxy group.
2-(Dichloromethyl)-4-(4-methylphenyl)-6-(methylthio)-1,3,5-triazine
C12H11Cl2N3S (299.00507060000007)
(4E)-2-[(E)-2-(4-chlorophenyl)ethenyl]-4-(furan-2-ylmethylidene)-1,3-oxazol-5-one
5-[(2-hydroxy-3-quinolinyl)methylene]-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione
(4Z)-2-(4-chlorophenyl)-4-[(E)-3-(furan-2-yl)prop-2-enylidene]-1,3-oxazol-5-one
N-acetyl-D-hexosamine 1-phosphate(2-)
C8H14NO9P-2 (299.04061640000003)
(NZ)-N-[3-(3-nitrophenyl)-1,4-benzothiazin-2-ylidene]hydroxylamine
4-amino-2-methyl-5-diphosphooxymethylpyrimidine
An aminopyrimidine that is pyrimidin-4-amine substituted by a methyl group at position 2 and a diphosphooxymethyl group at position 5.
N-acetyl-D-glucosamine 6-phosphate(2-)
C8H14NO9P (299.04061640000003)
Dianion of N-acetyl-D-glucosamine 6-phosphate arising from deprotonation of both OH groups of the phosphate.
N-acetyl-alpha-D-glucosamine 1-phosphate(2-)
C8H14NO9P (299.04061640000003)
Dianion of N-acetyl-alpha-D-glucosamine 1-phosphate arising from deprotonation of the phosphate OH groups; major species at pH 7.3.
Aminotrimethylene phosphonic acid
C3H12NO9P3 (298.97249320000003)
1-(4-sulfophenyl)-3-carboxy-4-amino-5-oxopyrazole
A 4,5-dihydropyrazole having p-sulfophenyl-, carboxy-, amino- and oxo substituents at the 1-, 3-, 4- and 5-positions respectively.
N-acetyl-D-mannosamine 6-phosphate(2-)
C8H14NO9P (299.04061640000003)
An organophosphate oxoanion resulting from the removal of both protons from the phosphate group of N-acetyl-D-mannosamine 6-phosphate.
N-acetyl-alpha-D-galactosamine 1-phosphate(2-)
C8H14NO9P (299.04061640000003)
An organophosphate oxoanion obtained by deprotonation of the phosphate OH groups of N-acetyl-alpha-D-galactosamine 1-phosphate; major species at pH 7.3.
N-acetyl-beta-D-glucosamine 6-phosphate(2-)
C8H14NO9P (299.04061640000003)
Dianion of N-acetyl-beta-D-glucosamine 6-phosphate.
1beta-methylseleno-N-acetyl-D-galactosamine
A monosaccharide derivative that is N-acetyl-beta-D-galactosamine in which the anomeric hydroxy group is replaced by a methylseleno group.